Comparison between Remus Pharmaceuticals IPO and Vasa Denticity IPO.
Remus Pharmaceuticals IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Vasa Denticity IPO is a SME Bookbuilding proposed to list at NSE SME.
| Remus Pharmaceuticals IPO | Vasa Denticity IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Beeline Capital Advisors Pvt.Ltd. | Hem Securities Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | MAS Services Ltd. |
| Market Maker | Sunflower Broking Pvt.Ltd. | Hem Finlease Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Remus Pharmaceuticals IPO is up to ₹45.29 Cr whereas the issue size of the Vasa Denticity IPO is up to ₹51.30 Cr. The final issue price of Remus Pharmaceuticals IPO is ₹1,229.00 per share and of Vasa Denticity IPO is ₹128.00 per share.
| Remus Pharmaceuticals IPO | Vasa Denticity IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹1,150.00 per share | ₹121.00 per share |
| Issue Price (Upper) | ₹1,229.00 per share | ₹128.00 per share |
| Issue Price (Final) | ₹1,229.00 per share | ₹128.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 100 shares | 1000 shares |
| Fresh Issue Size | 3,68,500 shares | 29,58,000 shares |
| Fresh Issue Size (Amount) | up to ₹45.29 Cr | up to ₹37.86 Cr |
| OFS Issue Size | 0 shares | 10,50,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹13.44 Cr |
| Issue Size Total | 3,68,500 shares | 40,08,000 shares |
| Issue Size Total (Amount) | up to ₹45.29 Cr | up to ₹51.30 Cr |
Remus Pharmaceuticals IPO opens on May 17, 2023, while Vasa Denticity IPO opens on May 23, 2023. The closing date of Remus Pharmaceuticals IPO and Vasa Denticity IPO is May 19, 2023, and May 25, 2023, respectively.
| Remus Pharmaceuticals IPO | Vasa Denticity IPO | |
|---|---|---|
| Anchor Bid Date | May 16, 2023 | May 22, 2023 |
| Issue Open | May 17, 2023 | May 23, 2023 |
| Issue Close | May 19, 2023 | May 25, 2023 |
| Basis Of Allotment (Tentative) | May 24, 2023 | May 30, 2023 |
| Initiation of Refunds (Tentative) | May 25, 2023 | May 31, 2023 |
| Credit of Share (Tentative) | May 26, 2023 | Jun 01, 2023 |
| Listing date (Tentative) | May 29, 2023 | Jun 02, 2023 |
| Anchor Lockin End date 1 | Jun 23, 2023 | Jun 29, 2023 |
| Anchor Lockin End date 2 | Aug 22, 2023 | Aug 28, 2023 |
Remus Pharmaceuticals IPO P/E ratio is 21.09, as compared to Vasa Denticity IPO P/E ratio of 30.62.
| Remus Pharmaceuticals IPO | Vasa Denticity IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 92.82 | 95.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 68.37 | 69.62 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 21.09 | 30.62 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹181.03 Cr. | ₹205.01 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 71.44% | 0.46% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 69.99% | 0.54% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.03 | 0.24 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹33.86 | ₹4.43 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 52.64% | 90.05% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Remus Pharmaceuticals IPO Retail Individual Investors (RII) are offered 1,29,000 shares while in Vasa Denticity IPO retail investors are offered 1,29,000 shares. Qualified Institutional Buyers (QIB) are offered 73,700 shares in Remus Pharmaceuticals IPO and 8,02,000 shares in Vasa Denticity IPO.
| Remus Pharmaceuticals IPO | Vasa Denticity IPO | |
|---|---|---|
| Anchor Investor Reserveration | 1,10,500 shares | 12,00,000 shares |
| Market Maker Reserveration | 19,500 shares | 2,16,000 shares |
| QIB | 73,700 shares | 8,02,000 shares |
| NII | 55,300 shares | 6,02,000 shares |
| RII | 1,29,000 shares | 14,04,000 shares |
| Employee | ||
| Others | ||
| Total | 3,68,500 shares | 40,08,000 shares |
Remus Pharmaceuticals IPO subscribed 57.21x in total, whereas Vasa Denticity IPO subscribed 73.14x.
| Remus Pharmaceuticals IPO | Vasa Denticity IPO | |
|---|---|---|
| QIB (times) | 10.75x | 37.26x |
| NII (times) | 229.31x | 156.09x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 49.81x | 58.07x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 57.21x | 73.14x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
